CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ 18,208	$ 13,701
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	72,949	66,528
Share-based compensation expense	3,203	3,389
Income from unconsolidated joint venture	(422)	(486)
Distributions from unconsolidated joint venture	885	750
(Gain) loss on sale of real estate, net	(1,991)	37
Changes in operating assets and liabilities:
Receivables and other assets, net	1,196	2,546
Accounts payable and accrued liabilities	(19,662)	(40,402)
Security deposits, prepaid rent and other liabilities	1,055	2,492
Net cash provided by operating activities	75,421	48,555
Cash flows from investing activities:
Investments in real estate	(41,338)	(18,592)
Development of real estate	(12,103)	(2,014)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(23,793)	(16,815)
Collection of real estate notes receivable	191	181
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(76,623)	(36,047)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	720,000	0
Payments on unsecured revolving credit facility	(415,000)	0
Payments on secured mortgage loans	(95,602)	(587)
Proceeds from issuance of common stock	50,020	0
Repurchase and cancellation of common stock	(4,624)	(11,926)
Dividends paid	(68,227)	(63,686)
Distributions paid to noncontrolling interest of limited partners	(1,509)	(1,364)
Net cash provided by (used in) financing activities	185,058	(77,563)
Net change in cash, cash equivalents and restricted cash	183,856	(65,055)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	221,472	68,475
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	18,208	13,701
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	72,949	66,528
Share-based compensation expense	3,203	3,389
Income from unconsolidated joint venture	(422)	(486)
Distributions from unconsolidated joint venture	885	750
(Gain) loss on sale of real estate, net	(1,991)	37
Changes in operating assets and liabilities:
Receivables and other assets, net	1,196	2,546
Accounts payable and accrued liabilities	(19,662)	(40,402)
Security deposits, prepaid rent and other liabilities	1,055	2,492
Net cash provided by operating activities	75,421	48,555
Cash flows from investing activities:
Investments in real estate	(41,338)	(18,592)
Development of real estate	(12,103)	(2,014)
Proceeds from the sale of real estate	6,420	1,193
Capital expenditures	(23,793)	(16,815)
Collection of real estate notes receivable	191	181
Advances on real estate notes receivable	(6,000)	0
Net cash used in investing activities	(76,623)	(36,047)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	720,000	0
Payments on unsecured revolving credit facility	(415,000)	0
Payments on secured mortgage loans	(95,602)	(587)
Proceeds from issuance of general partner units	50,020	0
Repurchase and cancellation of general partner units	(4,624)	(11,926)
Distributions paid to general partner	(68,227)	(63,686)
Distributions paid to limited partners and redeemable noncontrolling interests	(1,509)	(1,364)
Net cash provided by (used in) financing activities	185,058	(77,563)
Net change in cash, cash equivalents and restricted cash	183,856	(65,055)
Cash, cash equivalents and restricted cash - beginning of period	37,616	133,530
Cash, cash equivalents and restricted cash - end of period	$ 221,472	$ 68,475